CREATE EXTERNAL TABLE `euctrn_studies`(
`eudract_number` string,
`sponsors_protocol_code_number` string,
`national_competent_authority` string,
`clinical_trial_type` string,
`trial_status` string,
`date_on_which_this_record_was_first_entered_in_the_eudract_database` string,
`trial_results` string,
`member_state_concerned` string,
`eudract_number1` string,
`full_title_of_the_trial` string,
`name_or_abbreviated_title_of_the_trial_where_available` string,
`sponsors_protocol_code_number1` string,
`trial_is_part_of_a_paediatric_investigation_plan` string,
`ema_decision_number_of_paediatric_investigation_plan` string,
`name_of_sponsor` string,
`country` string,
`status_of_the_sponsor` string,
`name_of_organisation_providing_support` string,
`name_of_organisation` string,
`functional_name_of_contact_point` string,
`imp_role` string,
`imp_to_be_used_in_the_trial_has_a_marketing_authorisation` string,
`trade_name` string,
`name_of_the_marketing_authorisation_holder` string,
`country_which_granted_the_marketing_authorisation` string,
`the_imp_has_been_designated_in_this_indication_as_an_orphan_drug_in_the_community` string,
`orphan_drug_designation_number` string,
`product_name` string,
`product_code` string,
`pharmaceutical_form` string,
`specific_paediatric_formulation` string,
`routes_of_administration_for_this_imp` string,
`active_substance_of_chemical_origin` string,
`active_substance_of_biological_biotechnological_origin_other_than_advanced_therapy_imp_atimp` string,
`advanced_therapy_imp_atimp` string,
`somatic_cell_therapy_medicinal_product` string,
`gene_therapy_medical_product` string,
`tissue_engineered_product` string,
`combination_atimp_one_involving_a_medical_device` string,
`committee_on_advanced_therapies_cat_has_issued_a_classification_for_this_product` string,
`combination_product_that_includes_a_device_but_does_not_involve_an_advanced_therapy` string,
`radiopharmaceutical_medicinal_product` string,
`immunological_medicinal_product_such_as_vaccine_allergen_immune_serum` string,
`plasma_derived_medicinal_product` string,
`extractive_medicinal_product` string,
`recombinant_medicinal_product` string,
`medicinal_product_containing_genetically_modified_organisms` string,
`herbal_medicinal_product` string,
`homeopathic_medicinal_product` string,
`another_type_of_medicinal_product` string,
`other_medicinal_product_type` string,
`medical_conditions_being_investigated` string,
`condition_being_studied_is_a_rare_disease` string,
`main_objective_of_the_trial` string,
`secondary_objectives_of_the_trial` string,
`trial_contains_a_substudy` string,
`principal_inclusion_criteria` string,
`principal_exclusion_criteria` string,
`primary_end_points` string,
`diagnosis` string,
`prophylaxis` string,
`therapy` string,
`safety` string,
`efficacy` string,
`pharmacokinetic` string,
`pharmacodynamic` string,
`bioequivalence` string,
`dose_response` string,
`pharmacogenetic` string,
`pharmacogenomic` string,
`pharmacoeconomic` string,
`others` string,
`human_pharmacology_phase_i` string,
`first_administration_to_humans` string,
`bioequivalence_study` string,
`other` string,
`other_trial_type_description` string,
`therapeutic_exploratory_phase_ii` string,
`therapeutic_confirmatory_phase_iii` string,
`therapeutic_use_phase_iv` string,
`controlled` string,
`randomised` string,
`open` string,
`single_blind` string,
`double_blind` string,
`parallel_group` string,
`cross_over` string,
`other_medicinal_products` string,
`placebo` string,
`the_trial_involves_single_site_in_the_member_state_concerned` string,
`the_trial_involves_multiple_sites_in_the_member_state_concerned` string,
`the_trial_involves_multiple_member_states` string,
`trial_being_conducted_both_within_and_outside_the_eea` string,
`trial_being_conducted_completely_outside_of_the_eea` string,
`trial_has_a_data_monitoring_committee` string,
`definition_of_the_end_of_the_trial_and_justification_where_it_is_not_the_lastvisit_of_the_last_subject_undergoing_the_trial` string,
`in_the_member_state_concerned_years` string,
`in_the_member_state_concerned_months` string,
`in_the_member_state_concerned_days` string,
`trial_has_subjects_under_18` string,
`in_utero` string,
`preterm_newborn_infants_up_to_gestational_age_37_weeks` string,
`newborns_0_27_days` string,
`infants_and_toddlers_28_days23_months` string,
`children_211years` string,
`adolescents_1217_years` string,
`adults_1864_years` string,
`elderly_65_years` string,
`female` string,
`male` string,
`healthy_volunteers` string,
`patients` string,
`specific_vulnerable_populations` string,
`women_of_childbearing_potential_not_using_contraception` string,
`women_of_childbearing_potential_using_contraception` string,
`pregnant_women` string,
`nursing_women` string,
`emergency_situation` string,
`subjects_incapable_of_giving_consent_personally` string,
`in_the_member_state` string,
`plans_for_treatment_or_care_after_the_subject_has_ended_the_participation_in_the_trialif_it_is_different_from_the_expected_normal_treatment_of_that_condit`string,
`competent_authority_decision` string,
`date_of_competent_authority_decision` string,
`ethics_committee_opinion_of_the_trial_application` string,
`ethics_committee_opinion_reasons_for_unfavourable_opinion` string,
`date_of_ethics_committee_opinion` string,
`end_of_trial_status` string,
`date_of_the_global_end_of_the_trial` string) PARTITIONED BY (
p_y string
)
ROW FORMAT SERDE 'org.openx.data.jsonserde.JsonSerDe'
LOCATION 's3://hsdlc-results/euctrn-adapter/json'
TBLPROPERTIES (
'ignore.malformed.json'= 'true'
);

MSCK REPAIR TABLE euctrn_studies;
